Department of Medicine UNAM School of Medicine Windhoek, Namibia

Treatment of Chronic cancer of the blood (CLL) is getting into a brand new era. within the last five years, many new exciting medicine have entered the realm in hopes for successful in solidifying the unwellness. The medicine be completely different categories like BTK inhibitors, BCL-2 inhibitors, CD twenty protein, PI3 enzyme inhibitors, and Syk inhibitors. varied studies have shown that these agents have clinical activity each as initial medical care and as treatment of perennial unwellness. Novel ways combining or sequencing new agents with established therapy and chemoimmunotherapies combos square measure probably to vary the treatment of CLL within the close to future.

Lymphocytic; Leukemia; Car T cells; Obinutuzumab; Lenalidomide

Dheehama J. New Treatment Options for Chronic Lymphocytic Leukemia. Insights Journal of Surgery and Clinical Case Reports 2021.